An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis v...

Descrizione completa

Dettagli Bibliografici
Autori principali:	André, P, Groettrup, M, Klenerman, P, de Giuli, R, Booth, B, Cerundolo, V, Bonneville, M, Jotereau, F, Zinkernagel, R, Lotteau, V
Natura:	Journal article
Lingua:	English
Pubblicazione:	1998

Documenti analoghi

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
di: Cerundolo, V, et al.
Pubblicazione: (1998)

Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
di: Kelleher, A, et al.
Pubblicazione: (2001)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
di: Gileadi, U, et al.
Pubblicazione: (1999)

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
di: Klenerman, P, et al.
Pubblicazione: (1998)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
di: Anjali K. Gupta, et al.
Pubblicazione: (2007-04-01)

CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
di: Milicic, A, et al.
Pubblicazione: (2005)

Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome
di: Atul Pawar, et al.
Pubblicazione: (2020-01-01)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
di: Valmori, D, et al.
Pubblicazione: (1999)

Computational investigations of HIV-1 protease and protease inhibitors interactions
di: Sham, Hoi Fung
Pubblicazione: (2014)

The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
di: Cerundolo, V, et al.
Pubblicazione: (1997)

Current and Novel Inhibitors of HIV Protease
di: Jan Konvalinka, et al.
Pubblicazione: (2009-12-01)

Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
di: Johanna Bialas, et al.
Pubblicazione: (2015-01-01)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
di: Kourjian G, et al.
Pubblicazione: (2012-09-01)

Additivity in the Analysis and Design of HIV Protease Inhibitors
di: Jorissen, Robert N., et al.
Pubblicazione: (2012)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
di: V.B. Denisenko, et al.
Pubblicazione: (2010-02-01)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
di: V.B. Denisenko, et al.
Pubblicazione: (2010-02-01)

Proteasome inhibitors as anti-cancer agents.
di: Murray, R, et al.
Pubblicazione: (2000)

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
di: Valmori, D, et al.
Pubblicazione: (1999)

Down-regulation of Akt signaling with HIV-1 protease inhibitors
di: Gupta, A, et al.
Pubblicazione: (2005)

Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
di: Larissa da Costa Souza, et al.
Pubblicazione: (2014-01-01)

New proteasome inhibitors in the management of multiple myeloma
di: S. V. Semochkin
Pubblicazione: (2019-07-01)

MAPPING OF PATENTS RELATED TO PROTEASE INHIBITORS AND HIV
di: Romério Rodrigues dos Santos Silva, et al.
Pubblicazione: (2022-04-01)

Role of Gag in HIV Resistance to Protease Inhibitors
di: Fabrizio Mammano, et al.
Pubblicazione: (2010-07-01)

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2
di: Roberta Rinaldi, et al.
Pubblicazione: (2021-11-01)

TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation
di: Abhilash I. Chiramel, et al.
Pubblicazione: (2019-06-01)

Site-Specific Proteasome Inhibitors
di: Alexei F. Kisselev
Pubblicazione: (2021-12-01)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
di: Noah M. Merin, et al.
Pubblicazione: (2014-12-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
di: Christoph Driessen, et al.
Pubblicazione: (2016-03-01)

Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.
di: Hemelaar, J, et al.
Pubblicazione: (2001)

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
di: Nathalie Vigneron, et al.
Pubblicazione: (2015-09-01)

Evaluation of COVID-19 protease and HIV inhibitors interactions
di: Tran Linh, et al.
Pubblicazione: (2022-03-01)

Safety of protease inhibitors in HIV-infected pregnant women
di: Chougrani I, et al.
Pubblicazione: (2013-09-01)

Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).
di: Kathleen M S E Reyskens, et al.
Pubblicazione: (2013-01-01)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
di: Konvalinka Jan, et al.
Pubblicazione: (2011-08-01)

Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
di: Kann G, et al.
Pubblicazione: (2021-08-01)

Immune surveillance and AIDS progression.
di: Zinkernagel, R, et al.
Pubblicazione: (1997)

Correspondence - Immune surveillance and AIDS progression
di: Zinkernagel, R, et al.
Pubblicazione: (1997)

Of mice and men: cytotoxic T cells and AIDS pathogenesis.
di: Klenerman, P, et al.
Pubblicazione: (1999)

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?
di: Klenerman, P, et al.
Pubblicazione: (1997)

Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
di: J. Lopes, et al.
Pubblicazione: (2021-04-01)